So I wasn’t planning on being on the call today
Post# of 36537
(Total Views: 325)
Posted On: 01/21/2020 12:45:50 PM
So I wasn’t planning on being on the call today but as luck would have it I got to listen to the entire 2.5 hours. I didn’t take notes but this is my recap and understanding.
Dividend WILL be paid. No question.
Waiting on Finra to approve then will happen immediately. HOPEFULLY “in coming days”.
Once dividend is paid they can price the S1 and file the addendum. SEC responded quickly to the application and seem to only be waiting for the addendum.
NGIO will spin directly to NASDAQ. Unclear at this time what the valuation is or how many shares will be registered but Joe seemed to be pricing is in the $500M to $1B range. As NASDAQ minimum hare price will apply we should expect over $2 minimum.
Excelegen over $450K in November. Dec did not sound too good (due to the holidays)
Pantheon / MediSource one had over 200% growth. I forget which.
Regentys don’t remember any details given.
Side note - I believe Joe alluded to the plan with these. The AZ HMO / MSO / clinics will house Drs in various specialties. (Cardiology, Bariatric, podiatrist, etc) these Drs will be using products from GNBT companies and referring patients for each other’s services. That is where the real revs for Regentys and MediSource will come in. Where Excellagen will come from VA system and cosmetic applications.
Also one Re to AZ they secured or are in the process of securing a 4 suite surgical facility for the Drs to operate.
Roughly 90 days to build out AZ once funding is secured.
CMF Joe signed the release to remove the legend but was not concerned because they still had the waiver agreement and they had not filed the 13g. He does not know how many if any shares they still hold.
Veneto has no right to remove the legend because they did not turn over cash and additional assets due to GNBT but their lawyers sent letters to Broadridge and Broadridge remove the legend anyway. (GNBT will have a new transfer agent probably by March)
There was also some provision regarding criminal activity that Joe mentioned that I didn’t fully understand. Also violation of lock up leak out provision even if the legend had been removed legally.
GNBT Uplist. Sounds like this will be the last domino to fall.
MY GUESS as far as timeline.
Div by end of January
S1 for GNBT and separately NGIO ago in by Valentine’s Day
NGIO uplist by end of March (1Q 2020 calendar yr)
GNBT uplist by July 1
AZ clinic fully operational by Sept
No speculation from me on trials or FDA approvals, licensing deals or revenues.
Dividend WILL be paid. No question.
Waiting on Finra to approve then will happen immediately. HOPEFULLY “in coming days”.
Once dividend is paid they can price the S1 and file the addendum. SEC responded quickly to the application and seem to only be waiting for the addendum.
NGIO will spin directly to NASDAQ. Unclear at this time what the valuation is or how many shares will be registered but Joe seemed to be pricing is in the $500M to $1B range. As NASDAQ minimum hare price will apply we should expect over $2 minimum.
Excelegen over $450K in November. Dec did not sound too good (due to the holidays)
Pantheon / MediSource one had over 200% growth. I forget which.
Regentys don’t remember any details given.
Side note - I believe Joe alluded to the plan with these. The AZ HMO / MSO / clinics will house Drs in various specialties. (Cardiology, Bariatric, podiatrist, etc) these Drs will be using products from GNBT companies and referring patients for each other’s services. That is where the real revs for Regentys and MediSource will come in. Where Excellagen will come from VA system and cosmetic applications.
Also one Re to AZ they secured or are in the process of securing a 4 suite surgical facility for the Drs to operate.
Roughly 90 days to build out AZ once funding is secured.
CMF Joe signed the release to remove the legend but was not concerned because they still had the waiver agreement and they had not filed the 13g. He does not know how many if any shares they still hold.
Veneto has no right to remove the legend because they did not turn over cash and additional assets due to GNBT but their lawyers sent letters to Broadridge and Broadridge remove the legend anyway. (GNBT will have a new transfer agent probably by March)
There was also some provision regarding criminal activity that Joe mentioned that I didn’t fully understand. Also violation of lock up leak out provision even if the legend had been removed legally.
GNBT Uplist. Sounds like this will be the last domino to fall.
MY GUESS as far as timeline.
Div by end of January
S1 for GNBT and separately NGIO ago in by Valentine’s Day
NGIO uplist by end of March (1Q 2020 calendar yr)
GNBT uplist by July 1
AZ clinic fully operational by Sept
No speculation from me on trials or FDA approvals, licensing deals or revenues.
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼